S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Baker Bros Advisors/Q3 2024

Baker Bros Advisors

Periodo: Q3 2024 · Depositato: 2024-11-14
Vedi su SEC EDGAR
AUM
$9.65B
Valore totale del portafoglio
Posizioni
93
Titoli dichiarati
Prima Posizione
ONC
24.6% $2.37B
Var. Trimestrali
+6 / -8
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2024-11-14) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
ONCBeiGene, Ltd.$2.37B24.59%$224.51$297.65+32.6%
24.6%
INCYIncyte Corporation$2.03B21.06%$66.10$116.86+76.8%
21.1%
ACADACADIA Pharmaceuticals Inc.$659.5M6.83%$15.38$25.97+68.9%
6.8%
SMMTSummit Therapeutics Inc.$534.9M5.54%$21.90$15.42-29.6%
5.5%
MDGLMadrigal Pharmaceuticals, Inc.$419.1M4.34%$212.22$528.10+148.8%
4.3%
RVMDRevolution Medicines, Inc.$343.3M3.56%$45.35$189.24+317.3%
3.6%
RYTMRhythm Pharmaceuticals, Inc.$335.2M3.47%$52.39$114.17+117.9%
3.5%
INSMInsmed Incorporated$322.4M3.34%$73.00$111.60+52.9%
3.3%
KYMRKymera Therapeutics, Inc.$283.8M2.94%$47.33$113.51+139.8%
2.9%
BCYCBicycle Therapeutics plc$212.7M2.20%$22.63$4.35-80.8%
2.2%
EWTXEdgewise Therapeutics, Inc.$155.9M1.62%$26.69$39.56+48.2%
1.6%
REPLReplimune Group, Inc.$121.1M1.25%$10.96$11.58+5.7%
1.3%
ALKSAlkermes plc$117.0M1.21%$27.99$54.58+95.0%
1.2%
DNLIDenali Therapeutics Inc.$108.7M1.13%$29.13$25.83-11.3%
1.1%
Insmed Incorporated$98.3M1.02%
1.0%
RAREUltragenyx Pharmaceutical Inc.$87.5M0.91%$55.55$33.47-39.8%
0.9%
NRIXNurix Therapeutics, Inc.$87.2M0.90%$22.47$23.97+6.7%
0.9%
TRDAEntrada Therapeutics, Inc.$77.8M0.81%$15.98$7.72-51.7%
0.8%
IMTXImmatics N.V.$73.5M0.76%$11.41$9.95-12.8%
0.8%
ABCLAbCellera Biologics Inc.$71.6M0.74%$2.60$8.11+211.9%
0.7%
KNSAKiniksa Pharmaceuticals International, plc$70.4M0.73%$24.99$64.53+158.2%
0.7%
IGMSIGM Biosciences, Inc.$67.7M0.70%
0.7%
ARGXargenx SE$60.7M0.63%$542.08$939.68+73.3%
0.6%
STOKStoke Therapeutics, Inc.$53.7M0.56%$12.29$32.70+166.1%
0.6%
IMCRImmunocore Holdings plc$47.2M0.49%$31.13$32.50+4.4%
0.5%
KODKodiak Sciences Inc.$45.2M0.47%$2.61$38.54+1376.6%
0.5%
SERASera Prognostics, Inc.$42.4M0.44%$7.80$2.00-74.4%
0.4%
CRSPCRISPR Therapeutics AG$39.6M0.41%$46.98$60.08+27.9%
0.4%
XENEXenon Pharmaceuticals Inc.$39.1M0.41%$39.37$60.96+54.8%
0.4%
IMVTImmunovant, Inc.$34.9M0.36%$28.51$38.79+36.1%
0.4%

Attività Trimestre su Trimestre

Q3 2024 vs. Q2 2024

Nuove Posizioni (6)

TickerEmittenteNozionale
BCAXBicara Therapeutics Inc.$21.2M
ARVNArvinas, Inc.$10.0M
IONSIonis Pharmaceuticals, Inc.$8.9M
GPCRStructure Therapeutics Inc.$3.8M
WVEWave Life Sciences Ltd.$2.8M
ALGSAligos Therapeutics, Inc.$0.7M

Posizioni Chiuse (8)

TickerEmittenteNozionale
Insmed Incorporated$56.2M
CERECerevel Therapeutics Holdings, Inc.$27.9M
ATHAAthira Pharma, Inc.$8.4M
TLISTalis Biomedical Corporation$4.4M
ADAPYAdaptimmune Therapeutics plc$2.3M
SAGESage Therapeutics, Inc.$1.9M
ACHLAchilles Therapeutics plc$0.9M
ALGSAligos Therapeutics, Inc.$0.7M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
CRSPCRISPR Therapeutics AG$34.2M+743.1%+27.9%
SKYESkye Bioscience, Inc.$1.6M+186.9%
IMVTImmunovant, Inc.$22.7M+163.7%+36.1%
PRAXPraxis Precision Medicines, Inc.$13.2M+145.6%
CNTACentessa Pharmaceuticals plc$14.7M+123.4%
GBIOGeneration Bio Co.$1.4M+61.1%
INSMInsmed Incorporated$82.8M+23.5%+52.9%
XNCRXencor, Inc.$3.2M+22.9%

Ridotte (2)

TickerEmittenteNozionaleVar. Azioni
HOOKHOOKIPA Pharma Inc.$-1.3M-90.0%
NAMSNewAmsterdam Pharma Company N.V.$-0.3M-0.1%
Torna agli Hedge Fund